TCRR insider filings
TCR2 THERAPEUTICS INC. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2024-02-14. Screen TCRR transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for TCRR between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — TCR2 THERAPEUTICS INC.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2024-02-14 | 4 | TANG KEVIN C — 10% owner TANG CAPITAL MANAGEMENT LLC — 10% owner TANG CAPITAL PARTNERS LP — 10% owner | Other (J): 4,394,800 | EDGAR |
| 2023-06-05 | 4 | MPM SunStates Fund, L.P. — 10% owner MPM Asset Management Investors SunStates Fund LLC — 10% owner MPM SunStates Fund GP LLC — 10% owner MPM SunStates GP Managing Member LLC — 10% owner | Other (J): 4,158,964 @ $0 | EDGAR |
| 2023-06-05 | 4 | UBS Oncology Impact Fund L.P. — 10% owner Oncology Impact Fund (Cayman) Management L.P. — 10% owner BioImpact Capital LLC — 10% owner | Other (J): 3,370,982 @ $0 | EDGAR |
| 2023-06-05 | 4 | MPM BioVentures 2014, L.P. — 10% owner Foley Todd — 10% owner EVNIN LUKE — 10% owner MPM BioVentures 2014 (B), L.P. — 10% owner MPM Asset Management Investors BV2014 LLC — 10% owner MPM BioVentures 2014 LLC — 10% owner MPM BioVentures 2014 GP LLC — 10% owner MPM ASSET MANAGEMENT LLC — 10% owner | Other (J): 4,158,964 @ $0 | EDGAR |
| 2023-06-05 | 4 | GADICKE ANSBERT — Director, 10% owner | Other (J): 304,001 @ $0 · Other (J): 3,854,963 @ $0 · Other (J): 3,370,982 @ $0 | EDGAR |
| 2023-06-01 | 4 | Cardama Alfonso Quintas — Chief Medical Officer | Disposition to issuer (D): 109,459 · Disposition to issuer (D): 70,649 (derivative) @ $0 · Disposition to issuer (D): 31,582 (derivative) @ $0 · Disposition to issuer (D): 42,346 (derivative) @ $0 · Disposition to issuer (D): 90,720 (derivative) @ $0 · Disposition to issuer (D): 114,700 (derivative) @ $0 · +4 more | EDGAR |
| 2023-06-01 | 4 | Olagunju Peter — Chief Operating Officer | Disposition to issuer (D): 24,092 · Disposition to issuer (D): 98,124 (derivative) @ $0 · Disposition to issuer (D): 47,100 (derivative) @ $0 · Disposition to issuer (D): 16,354 (derivative) @ $0 · Disposition to issuer (D): 62,047 (derivative) @ $0 | EDGAR |
| 2023-06-01 | 4 | Harrison Rosemary — Chief Business & Strategy | Disposition to issuer (D): 76,930 (derivative) @ $0 · Disposition to issuer (D): 12,822 (derivative) @ $0 · Disposition to issuer (D): 191,102 (derivative) @ $0 | EDGAR |
| 2023-06-01 | 4 | Hoos Axel — Director | Disposition to issuer (D): 16,800 (derivative) @ $0 · Disposition to issuer (D): 9,596 (derivative) @ $0 · Disposition to issuer (D): 12,100 (derivative) @ $0 · Disposition to issuer (D): 12,100 (derivative) @ $0 | EDGAR |
| 2023-06-01 | 4 | Hegde Priti — Director | Disposition to issuer (D): 16,800 (derivative) @ $0 · Disposition to issuer (D): 12,100 (derivative) @ $0 · Disposition to issuer (D): 24,968 (derivative) @ $0 | EDGAR |
| 2023-06-01 | 4 | Justice Angela — Chief People Officer | Disposition to issuer (D): 48,745 · Disposition to issuer (D): 78,499 (derivative) @ $0 · Disposition to issuer (D): 76,500 (derivative) @ $0 · Disposition to issuer (D): 13,083 (derivative) @ $0 · Disposition to issuer (D): 13,527 (derivative) @ $0 · Disposition to issuer (D): 1,050 (derivative) @ $0 · +1 more | EDGAR |
| 2023-06-01 | 4 | Tomasello Shawn — Director | Disposition to issuer (D): 16,800 (derivative) @ $0 · Disposition to issuer (D): 12,100 (derivative) @ $0 · Disposition to issuer (D): 15,191 (derivative) @ $0 · Disposition to issuer (D): 4,177 (derivative) @ $0 | EDGAR |
| 2023-06-01 | 4 | Sullivan Eric — Chief Financial Officer | Disposition to issuer (D): 40,820 (derivative) @ $0 · Disposition to issuer (D): 250,000 (derivative) @ $0 · Disposition to issuer (D): 6,804 (derivative) @ $0 | EDGAR |
| 2023-06-01 | 4 | Menzel Garry E — President and CEO, Director | Disposition to issuer (D): 132,729 · Disposition to issuer (D): 132,730 · Disposition to issuer (D): 138,871 · Disposition to issuer (D): 138,031 (derivative) @ $0 · Disposition to issuer (D): 433,037 (derivative) @ $0 · Disposition to issuer (D): 305,800 (derivative) @ $0 · +5 more | EDGAR |
| 2023-06-01 | 4 | Gibson Neil W — Director | Disposition to issuer (D): 16,800 (derivative) @ $0 · Disposition to issuer (D): 6,270 (derivative) @ $0 · Disposition to issuer (D): 5,000 (derivative) @ $0 · Disposition to issuer (D): 12,100 (derivative) @ $0 · Disposition to issuer (D): 12,100 (derivative) @ $0 · Disposition to issuer (D): 8,072 (derivative) @ $0 | EDGAR |
| 2023-06-01 | 4 | Webster Stephen W — Director | Disposition to issuer (D): 16,800 (derivative) @ $0 · Disposition to issuer (D): 12,100 (derivative) @ $0 · Disposition to issuer (D): 12,100 (derivative) @ $0 · Disposition to issuer (D): 10,482 (derivative) @ $0 | EDGAR |
| 2023-06-01 | 4 | Allen Andrew R — Director | Disposition to issuer (D): 16,800 (derivative) @ $0 · Disposition to issuer (D): 12,100 (derivative) @ $0 · Disposition to issuer (D): 12,100 (derivative) @ $0 · Disposition to issuer (D): 5,000 (derivative) @ $0 · Disposition to issuer (D): 6,270 (derivative) @ $0 · Disposition to issuer (D): 8,072 (derivative) @ $0 | EDGAR |
| 2023-05-30 | 4 | TANG KEVIN C — 10% owner TANG CAPITAL MANAGEMENT LLC — 10% owner TANG CAPITAL PARTNERS LP — 10% owner | Purchase (P): 50,000 @ $1.72 | EDGAR |
| 2023-05-24 | 4 | MPM ASSET MANAGEMENT LLC — 10% owner EVNIN LUKE — 10% owner | Option exercise/expiry (X): 178,269 @ $0.74 · Sale (S): 70,170 @ $1.88 · Option exercise/expiry (X): 42,761 (derivative) @ $0 · Option exercise/expiry (X): 135,508 (derivative) @ $0 | EDGAR |
| 2023-05-24 | 4 | GADICKE ANSBERT — Director, 10% owner | Option exercise/expiry (X): 178,269 @ $0.74 · Sale (S): 70,170 @ $1.88 · Option exercise/expiry (X): 42,761 (derivative) @ $0 · Option exercise/expiry (X): 135,508 (derivative) @ $0 | EDGAR |
| 2023-05-15 | 4 | TANG KEVIN C — 10% owner TANG CAPITAL MANAGEMENT LLC — 10% owner TANG CAPITAL PARTNERS LP — 10% owner | Purchase (P): 38,765 @ $1.95 · Purchase (P): 6,183 @ $1.95 | EDGAR |
| 2023-05-10 | 4 | TANG KEVIN C — 10% owner TANG CAPITAL MANAGEMENT LLC — 10% owner TANG CAPITAL PARTNERS LP — 10% owner | Purchase (P): 57,073 @ $1.95 · Purchase (P): 20,141 @ $1.95 · Purchase (P): 6,774 @ $1.95 | EDGAR |
| 2023-05-05 | 4 | TANG KEVIN C — 10% owner TANG CAPITAL MANAGEMENT LLC — 10% owner TANG CAPITAL PARTNERS LP — 10% owner | Purchase (P): 18,513 @ $1.85 · Purchase (P): 104,241 @ $1.86 · Purchase (P): 95,759 @ $1.90 · Purchase (P): 71,064 @ $1.94 | EDGAR |
| 2022-12-19 | 4 | Cardama Alfonso Quintas — Chief Medical Officer | Grant/award (A): 70,649 (derivative) @ $0 · Grant/award (A): 11,775 (derivative) @ $0 | EDGAR |
| 2022-12-19 | 4 | Olagunju Peter — Chief Technical Officer | Grant/award (A): 98,124 (derivative) @ $0 · Grant/award (A): 16,354 (derivative) @ $0 | EDGAR |
| 2022-12-19 | 4 | Hoos Axel — Director | Grant/award (A): 16,800 (derivative) @ $0 | EDGAR |
| 2022-12-19 | 4 | Hegde Priti — Director | Grant/award (A): 16,800 (derivative) @ $0 | EDGAR |
| 2022-12-19 | 4 | Harrison Rosemary — Chief Business & Strategy | Grant/award (A): 76,930 (derivative) @ $0 · Grant/award (A): 12,822 (derivative) @ $0 | EDGAR |
| 2022-12-19 | 4 | Justice Angela — Chief People Officer | Grant/award (A): 78,499 (derivative) @ $0 · Grant/award (A): 13,083 (derivative) @ $0 | EDGAR |
| 2022-12-19 | 4 | Tomasello Shawn — Director | Grant/award (A): 16,800 (derivative) @ $0 | EDGAR |
| 2022-12-19 | 4 | Sullivan Eric — Chief Financial Officer | Grant/award (A): 40,820 (derivative) @ $0 · Grant/award (A): 6,804 (derivative) @ $0 | EDGAR |
| 2022-12-19 | 4 | Menzel Garry E — President and CEO, Director | Grant/award (A): 238,008 (derivative) @ $0 · Grant/award (A): 39,681 (derivative) @ $0 | EDGAR |
| 2022-12-19 | 4 | Gibson Neil W — Director | Grant/award (A): 16,800 (derivative) @ $0 | EDGAR |
| 2022-12-19 | 4 | Webster Stephen W — Director | Grant/award (A): 16,800 (derivative) @ $0 | EDGAR |
| 2022-12-19 | 4 | Allen Andrew R — Director | Grant/award (A): 16,800 (derivative) @ $0 | EDGAR |
| 2022-12-13 | 4 | Cardama Alfonso Quintas — Chief Medical Officer | Sale (S): 4,461 @ $1.13 · Sale (S): 4,586 @ $1.10 · Sale (S): 4,752 @ $1.06 | EDGAR |
| 2022-12-13 | 4 | Olagunju Peter — Chief Technical Officer | Sale (S): 1,561 @ $1.13 · Sale (S): 1,610 @ $1.10 · Sale (S): 1,659 @ $1.06 | EDGAR |
| 2022-12-13 | 4 | Justice Angela — Chief People Officer | Sale (S): 2,792 @ $1.13 · Sale (S): 2,865 @ $1.10 · Sale (S): 2,963 @ $1.06 | EDGAR |
| 2022-12-13 | 4 | Menzel Garry E — President and CEO, Director | Sale (S): 10,325 @ $1.13 · Sale (S): 10,613 @ $1.10 · Sale (S): 11,000 @ $1.06 | EDGAR |
| 2022-12-09 | 4 | Cardama Alfonso Quintas — Chief Medical Officer | Sale (S): 3,928 @ $1.28 · Sale (S): 4,014 @ $1.26 | EDGAR |
| 2022-12-09 | 4 | Olagunju Peter — Chief Technical Officer | Sale (S): 1,378 @ $1.28 · Sale (S): 1,410 @ $1.25 | EDGAR |
| 2022-12-09 | 4 | Justice Angela — Chief People Officer | Sale (S): 2,457 @ $1.28 · Sale (S): 2,511 @ $1.25 | EDGAR |
| 2022-12-09 | 4 | Menzel Garry E — President and CEO, Director | Sale (S): 9,111 @ $1.28 · Sale (S): 9,314 @ $1.25 | EDGAR |
| 2022-12-07 | 4 | Cardama Alfonso Quintas — Chief Medical Officer | Sale (S): 3,686 @ $1.37 · Sale (S): 3,778 @ $1.33 | EDGAR |
| 2022-12-07 | 4 | Olagunju Peter — Chief Technical Officer | Sale (S): 1,291 @ $1.37 · Sale (S): 1,327 @ $1.33 | EDGAR |
| 2022-12-07 | 4 | Justice Angela — Chief People Officer | Sale (S): 2,302 @ $1.37 · Sale (S): 2,361 @ $1.33 | EDGAR |
| 2022-12-07 | 4 | Menzel Garry E — President and CEO, Director | Sale (S): 8,530 @ $1.37 · Sale (S): 14,886 @ $1.35 | EDGAR |
| 2022-12-05 | 4 | Olagunju Peter — Chief Technical Officer | Option exercise (M): 33,409 · Sale (S): 1,273 @ $1.39 · Option exercise (M): 33,409 (derivative) @ $0 | EDGAR |
| 2022-12-05 | 4 | Justice Angela — Chief People Officer | Option exercise (M): 59,576 · Sale (S): 2,273 @ $1.39 · Option exercise (M): 50,889 (derivative) @ $0 · Option exercise (M): 2,840 (derivative) @ $0 · Option exercise (M): 5,847 (derivative) @ $0 | EDGAR |
| 2022-12-05 | 4 | Menzel Garry E — President & CEO, Director | Option exercise (M): 221,058 · Sale (S): 8,408 @ $1.39 · Option exercise (M): 158,795 (derivative) @ $0 · Option exercise (M): 40,881 (derivative) @ $0 · Option exercise (M): 21,382 (derivative) @ $0 | EDGAR |
Recent 8-K events — TCR2 THERAPEUTICS INC.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2023-06-01 | 8-K | 2.01 — Completion of Acquisition or Disposition of Assets 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-05-30 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-05-24 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-05-22 | 8-K | 8.01 — Other Events | EDGAR |
| 2023-05-11 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-03-23 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-03-10 | 8-K | 7.01 — Regulation FD Disclosure | EDGAR |
| 2023-03-06 | 8-K | 1.01 — Entry into a Material Definitive Agreement 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-01-05 | 8-K | ? 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-01-03 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=TCRR returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs